Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04449822
Other study ID # 07122017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 5, 2017
Est. completion date March 5, 2022

Study information

Verified date April 2022
Source Tbilisi State Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study evaluates and compares effect of emergency surgery and colonic stents for treatment of malignant colonic obstructions.


Description:

Acute colonic obstruction is one of the common clinical presentations of colorectal cancer. Surgical decompression with colostomy with or without resection and eventual re-anastomosis is the treatment of choice; however, emergency surgery is associated with higher morbidity and mortality. The colonic stent insertion effectively decompressed the obstructed colon and avoid needs of emergency surgery. This method is a palliation and bridge to surgery. Colonic stents allowed surgery to be performed electively.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date March 5, 2022
Est. primary completion date December 5, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient with malignant colorectal obstructions. - Patient's approval to participate in the study. Exclusion Criteria: - Patient's preference for either treatment method. - Patient's refusal to participate in the study. - Patients in the ASA group 4 and 5.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Emergency surgery
Surgical decompression with colostomy with or without resection and eventual re-anastomosis.
Colonic stenting
The colonic stent placement to relieve the colonic obstruction.

Locations

Country Name City State
Georgia Tbilisi State Medical University Tbilisi Yes

Sponsors (1)

Lead Sponsor Collaborator
Zaza Demetrashvili

Country where clinical trial is conducted

Georgia, 

References & Publications (1)

Merabishvili G, Agdgomelashvili I, Mosidze B, Demetrashvili Z. Emergency surgery versus colorectal stenting for the management of left-sided malignant colon obstructions:A prospective cohort study. Acta Scientific Medical Sciences 2021, 5(4):18-23. doi: 1

Outcome

Type Measure Description Time frame Safety issue
Primary The time of clinical relieve of obstruction 24 hours after surgery/procedure
Secondary Stent related complications perforation, migration, stent obstruction time of hospital stay, an average 10 day.
Secondary Mortality 30-day mortality 30 day after surgery/procedure
Secondary Blood loss Blood loss during emergency surgery or during colonic stenting. time of surgery/procedure
Secondary operation time duration of surgery/procedure during surgery/procedure
Secondary Overall complications complications which developed in postoperative period 30 day after surgery/procedure
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A